TSX:CRONPharmaceuticals
Cronos Group (TSX:CRON) Has Investors Asking A Bigger Question
Cronos Group stock reacts to new product launches in Canada
Cronos Group (TSX:CRON) has drawn fresh attention after expanding its SOURZ by Spinach edible multipacks with a new Blue Raspberry Lemonade live resin gummy, alongside added flavors in its Spinach vape cartridge range.
The new SOURZ by Spinach launches come as Cronos Group trades around CA$4.50, with a 90 day share price return of 14.8% and a year to date share price return of 21.95%. That sits alongside a 1 year total shareholder...

